Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Consun Pharmaceutical Group Ltd. ( (HK:1681) ) is now available.
Consun Pharmaceutical Group Ltd. announced changes in its Nomination Committee, effective June 20, 2025, with Mr. An Meng stepping down and Dr. Zhang Lihua joining as a member. This change aligns with the updated Corporate Governance Code and aims to enhance the company’s governance practices, thereby potentially improving its overall performance and diversity.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products.
Average Trading Volume: 2,346,318
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.36B
For a thorough assessment of 1681 stock, go to TipRanks’ Stock Analysis page.